Your browser doesn't support javascript.
loading
miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.
Sun, Yanqin; Hu, Bingshuang; Wang, Yanhong; Li, Zhen; Wu, Jingfang; Yang, Yunchu; Wei, Yue; Peng, Xiaofeng; Chen, Hongling; Chen, Rongqi; Jiang, Pingyan; Fang, Sixian; Yu, Zhiwu; Guo, Linlang.
Afiliação
  • Sun Y; Department of Pathology, Guangdong Medical University, Dongguan, China.
  • Hu B; Department of Radiotherapy, Zhongshan People's Hospital, Zhongshan, China.
  • Wang Y; Department of Gynecology, Jinxiang People's Hospital, Jining, China.
  • Li Z; Department of Pathology, Guangdong Medical University, Dongguan, China.
  • Wu J; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China, linlangg@yahoo.com.
  • Yang Y; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China, linlangg@yahoo.com.
  • Wei Y; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Peng X; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Chen H; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Chen R; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Jiang P; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Fang S; College of Pharmacy, Guangdong Medical University, Dongguan, China.
  • Yu Z; Division of Laboratory Science, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
  • Guo L; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China, linlangg@yahoo.com.
Cancer Manag Res ; 10: 4735-4745, 2018.
Article em En | MEDLINE | ID: mdl-30425570
ABSTRACT

OBJECTIVE:

microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. MATERIALS AND

METHODS:

All the experimental methods used were as follows microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student's t-test or one-way ANOVA. P <0.05 (typically compared with the negative control group) was considered as significant and is marked with an asterisk in the figures.

RESULTS:

In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3'-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle.

CONCLUSION:

Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China